accountits aging branded drug portfolio and left a $3.6 billion cash offer on the table to buy King Pharmaceuticals Incorporated (NYSE:KG) (Bristol, Tennessee). It is just the latest round of acquisitions in the Pharmaceutical Industry as companies scramble to...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Cash Is King to the Tune of $3.6 Billion in Pfizer Offer, an Industrial Info News Alert
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account